Evidence map›Paper›PMID 38960710›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2024

PET/CT-Based Absorbed Dose Maps in

Zhonglin Lu, Daniel F Polan, Lise Wei, Madhava P Aryal, Kellen Fitzpatrick, Chang Wang, Kyle C Cuneo, Joseph R Evans, Molly E Roseland, Joseph J Gemmete and 6 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Zhonglin LuBiomedical Imaging Laboratory, Department of Electrical and Computer Engineering, Faculty of Science and Technology, University of Macau, Taipa, China.
Daniel F PolanDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Lise WeiDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Madhava P AryalDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Kellen FitzpatrickDepartment of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan.
Chang WangDepartment of Biostatistics, University of Michigan, Ann Arbor, Michigan.
Kyle C CuneoDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Joseph R EvansDepartment of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Molly E RoselandDepartment of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan.
Joseph J GemmeteDepartment of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan.
Jared A ChristensenDepartment of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan.
Baljendra S KapoorDepartment of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan.
Justin K MikellDepartment of Radiation Oncology, Washington University in St. Louis, St. Louis, Missouri.
Yue CaoDepartment of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan.
Greta S P MokBiomedical Imaging Laboratory, Department of Electrical and Computer Engineering, Faculty of Science and Technology, University of Macau, Taipa, China; yuni@med.umich.edu gretamok@um.edu.mo.
Yuni K DewarajaDepartment of Radiology, University of Michigan Medical Center, Ann Arbor, Michigan; yuni@med.umich.edu gretamok@um.edu.mo.

Funding

Imaging and Dosimetry of Yttrium-90 for Personalized Cancer TreatmentR01EB022075 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DEWARAJA, YUNI K · 2016 to 2023
$4.7M
NIBIB NIH HHS R01 EB022075
6 · The paper itself

Abstract

Functional liver parenchyma can be damaged from treatment of liver malignancies with

Indexed as

LiverMagnetic Resonance ImagingPositron Emission Tomography Computed TomographyYttrium RadioisotopesAgedFemaleGadolinium DTPAHumansLiver Function TestsLiver NeoplasmsMaleMiddle AgedRadiotherapy DosageGadolinium DTPAgadolinium ethoxybenzyl DTPAYttrium-90Yttrium Radioisotopes90Y PET/CTabsorbed dose–toxicity relationshipDGAE MRIdosimetrySIRT

Identifiers

PMID38960710
PMCPMC11294069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.